Researchers have made a groundbreaking discovery in the fight against cancer, finding that intravenous administration of vitamin C can reach high concentrations in the body, potentially damaging vulnerable cancer cells. This breakthrough challenges previous assumptions that vitamin C supplements were ineffective in treating cancer.
Key Insights
Intravenous vitamin C has been shown to reach vastly higher concentrations than oral supplements, behaving like an experimental cancer drug that targets and damages vulnerable cancer cells. Early studies suggest that this treatment method could not only reduce the side effects of traditional cancer treatments but also improve patient outcomes, offering new hope in the battle against this devastating disease.
